Last reviewed · How we verify
NCT04975854
Virtual Reality Exposure Therapy for Acrophobia
NA trial testing Exposure Therapy (Virtual Reality) in Specific Phobia in 43 participants. Completed in 17 June 2022.
17 June 2022
Quick facts
| Lead sponsor | National Institute of Mental Health, Czech Republic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 43 |
| Start date | 13 July 2021 |
| Primary completion | 17 June 2022 |
| Estimated completion | 17 June 2022 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Exposure Therapy (Virtual Reality)
- Information Session
Conditions studied
- Specific Phobia — all drugs for Specific Phobia →
- Acrophobia — all drugs for Acrophobia →
- Fear of Heights — all drugs for Fear of Heights →
- Anxiety Disorders — all drugs for Anxiety Disorders →
Sponsor
National Institute of Mental Health, Czech Republic
Who can join
Adults 18 to 64, any sex, with Specific Phobia or Acrophobia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to examine the efficacy of virtual reality exposure therapy (VRET) as a treatment for specific phobia (acrophobia). The study will randomly assign 42 participants with acrophobia to one of two conditions: a) the experimental condition (consisting of 3 sessions of virtual reality exposure) or b) a control condition. Both groups will receive short information session about general principles of exposure therapy before the start of the study. After the end of the study, the waitlist group will be invited to attend the short version (one or two-sessions) of the VRET. Both groups will receive a final follow-up questionnaires 2 months after the last session.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04975854
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exposure Therapy (Virtual Reality)
Trials testing the same drug.
- NCT07245134 — Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients · NA · recruiting
- NCT04737915 — Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights · NA · completed
Other recruiting trials for Specific Phobia
Currently open trials in the same condition.
- NCT07228143 — Stepped Care Treatment for Anxiety Resilience · NA · recruiting
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT06942429 — Stepped Versus Stratified Care for Anxiety Disorders in Youth · NA · recruiting
- NCT06788119 — Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders · NA · recruiting
- NCT04563390 — Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia. · NA · recruiting
Other National Institute of Mental Health, Czech Republic trials
Trials by the same sponsor.
- NCT07064629 — Training of Relaxation Breathing in Virtual Reality Using Biofeedback: Comparison Study · NA · enrolling by invitation
- NCT06915883 — Experiential and Relaxation Virtual Reality as a Tool for Easing Anxiety in Seriously Ill Children · NA · recruiting
- NCT07206199 — Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: Outpatients Trial · NA · recruiting
- NCT07245134 — Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients · NA · recruiting
- NCT04876144 — Kogito: App to Reduce Perinatal Psychosocial Stress · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04975854 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Mental Health, Czech Republic
- Last refreshed: 16 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04975854.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing